Virtu Financial LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$44
-99.8%
39,169
+205.4%
0.01%
+200.0%
Q3 2022$21,000
-19.2%
12,824
-21.1%
0.00%0.0%
Q1 2022$26,000
-29.7%
16,261
-7.9%
0.00%
-50.0%
Q4 2021$37,000
+15.6%
17,663
+20.3%
0.00%
+100.0%
Q1 2021$32,000
-79.6%
14,683
-73.2%
0.00%
-86.7%
Q4 2019$157,000
+46.7%
54,738
+208.3%
0.02%
+114.3%
Q3 2018$107,00017,7520.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders